Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology
JAC-Antimicrobial Resistance · 05.03.2024 · 6 (2)
DOI: 10.1093/jacamr/dlae051 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 22.03.2024. Verfasst von Hafsah Deepa Tootla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Microbiology, National Health Laboratory Service, Red Cross War Memorial Children's Hospital, Cape Town, South Africa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, National Research Foundation South Africa.
Abstract (Originalsprache)
Background
Carbapenem-resistant Enterobacterales (CRE) are a substantial problem in Cape Town. CRE epidemiology is largely unknown and mortality remains high.
Objectives
To describe and characterize the clinical and microbiological epidemiology of CRE within Cape Town hospitals to better inform therapy with regard to current and novel antibiotics, as well as improve antimicrobial stewardship (AMS), and infection prevention and control (IPC).
Methods
This prospective, multicentre study performed between 1 November 2020 and 30 November 2022, across three public and three private hospitals included hospitalized participants with CRE from clinical cultures. Participant demographics, clinical information and microbiology results were collected and analysed.
Results
Ninety percent of participants were from public hospitals. The age distribution ranged from 7 days to 88 years. Notable risk factors for CRE infection included recent exposure to antibiotics, medical devices and surgery. The most prevalent species was Klebsiella pneumoniae. However, a higher proportion of Serratia marcescens compared with previous reports was identified. The detected carbapenemases were blaOXA-48-like (80%) and blaNDM (11%). With the exception of amikacin (63%), tigecycline (65%), colistin (95%) and ceftazidime/avibactam (87%), susceptibility to antibiotics was low.
Conclusions
This study identified common risk factors for CRE infection and generated a description of carbapenemase enzymes, species distribution and antibiograms, enabling a better understanding of CRE epidemiology. This provides insights into transmission patterns and resistance determinants of CREs, beneficial to informing data-driven regional patient management, AMS and IPC strategies.
Autor:innen und Institutionen
- Division of Medical Microbiology, National Health Laboratory Service, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
- Division of Medical Microbiology, National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.
- Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
- Division of Medical Microbiology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
- Division of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Division of Medical Microbiology, Pathcare, Cape Town, South Africa.
ORCID-Profile: Hafsah Deepa Tootla, Elizabeth Prentice, Clinton Moodley, Gert Marais, Abraham Niehaus, Adrian Brink
Förderung
- Pfizer
- National Research Foundation South Africa
Zitieren
APA
Tootla, H. D., Prentice, E., Moodley, C., Marais, G., Nyakutira, N., Reddy, K., Bamford, C., Niehaus, A., Whitelaw, A., Brink, A., & Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA) (2024). Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology. JAC-Antimicrobial Resistance, 6(2). https://doi.org/10.1093/jacamr/dlae051
Vancouver
Tootla HD, Prentice E, Moodley C, Marais G, Nyakutira N, Reddy K, et al. Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology. JAC-Antimicrobial Resistance. 2024;6(2). doi:10.1093/jacamr/dlae051
BibTeX
@article{Tootla2024,
author = {Tootla, Hafsah Deepa and Prentice, Elizabeth and Moodley, Clinton and Marais, Gert and Nyakutira, Nyasha and Reddy, Kessendri and Bamford, Colleen and Niehaus, Abraham and Whitelaw, Andrew and Brink, Adrian and Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA), Members (collaborators) of the Cape Town Antimicrobial Stewardship Study Alliance (CT-ASSA)},
title = {Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology},
journal = {JAC-Antimicrobial Resistance},
year = {2024},
volume = {6},
number = {2},
doi = {10.1093/jacamr/dlae051}
}
EUVIMED